Viewing Study NCT00438204


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2025-12-25 @ 7:01 PM
Study NCT ID: NCT00438204
Status: TERMINATED
Last Update Posted: 2021-04-13
First Post: 2007-02-20
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization: